New Zealand prescribing advice unchanged despite COVID trial evidence

+News

New Zealand prescribing advice unchanged despite COVID trial evidence

NZD

New Zealand Doctor Rata Aotearoa

molnupiravir
A British trial found molnupiravir (Lagevrio) did not reduce hospital admissions or deaths [image: supplied]
“For most people that are eligible, Paxlovid is the oral antiviral of choice” COVID-19 antiviral prescribing guidance will not change in New Zea